Market News

$-0.20 EPS Expected for Juniper Pharmaceuticals, Inc. (JNP); Pine Brook Road Advisors LP Lowered By $85.24 Million Its Essent Group LTD (ESNT) Position

Pine Brook Road Advisors Lp decreased Essent Group Ltd (ESNT) stake by 31.63% reported in 2017Q3 SEC filing. Pine Brook Road Advisors Lp sold 2.13M shares as Essent Group Ltd (ESNT)’s stock rose 0.42%. The Pine Brook Road Advisors Lp holds 4.61M shares with $186.58 million value, down from 6.74M last quarter. Essent Group Ltd now has $4.65B valuation. The stock increased 0.77% or $0.36 during the last trading session, reaching $47.23. About 291,893 shares traded. Essent Group Ltd. (NYSE:ESNT) has risen 81.69% since February 18, 2017 and is uptrending. It has outperformed by 64.99% the S&P500.

Analysts expect Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) to report $-0.20 EPS on March, 6.They anticipate $1.08 EPS change or 122.73% from last quarter’s $0.88 EPS. After having $-0.08 EPS previously, Juniper Pharmaceuticals, Inc.’s analysts see 150.00% EPS growth. The stock increased 1.75% or $0.15 during the last trading session, reaching $8.7. About 39,444 shares traded. Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) has declined 42.39% since February 18, 2017 and is downtrending. It has underperformed by 59.09% the S&P500.

Juniper Pharmaceuticals, Inc., a women's health therapeutic company, focuses on developing therapeutics that address unmet medical needs in women's health. The company has market cap of $94.34 million. The firm develops its products using its drug delivery technologies, including bioadhesive delivery system, a polymer designed to adhere to epithelial surfaces or mucosa for sustained and controlled delivery of active drug product; and a novel intra-vaginal ring technology. It has a 13.94 P/E ratio. It markets CRINONE, a progesterone bioadhesive vaginal gel for progesterone supplementation or replacement as part of an assisted reproductive technology treatment for infertile women with progesterone deficiency.

Among 5 analysts covering Juniper Pharmaceuticals Inc (NASDAQ:JNP), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Juniper Pharmaceuticals Inc had 7 analyst reports since August 26, 2015 according to SRatingsIntel. On Thursday, August 18 the stock rating was downgraded by Northland Capital to “Market Perform”. The stock has “Buy” rating by TheStreet on Wednesday, August 26. Northland Capital initiated the stock with “Outperform” rating in Tuesday, January 26 report. The stock of Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) has “Market Perform” rating given on Monday, January 9 by Bernstein. The rating was initiated by Roth Capital on Tuesday, January 2 with “Buy”. The firm earned “Neutral” rating on Friday, August 19 by H.C. Wainwright.

Since August 14, 2017, it had 0 insider buys, and 6 sales for $965,850 activity. $203,305 worth of Essent Group Ltd. (NYSE:ESNT) was sold by Gibbons Mary Lourdes. Another trade for 7,000 shares valued at $315,070 was sold by MCALEE LAWRENCE E JR. WEINSTOCK DAVID B sold $77,900 worth of stock.

Investors sentiment increased to 1.75 in 2017 Q3. Its up 0.39, from 1.36 in 2017Q2. It increased, as 19 investors sold ESNT shares while 58 reduced holdings. 44 funds opened positions while 91 raised stakes. 83.02 million shares or 4.73% more from 79.27 million shares in 2017Q2 were reported. 652,043 were accumulated by Fil Ltd. Ameritas Investment accumulated 6,781 shares or 0.01% of the stock. Principal Fin Group Inc Inc has invested 0% in Essent Group Ltd. (NYSE:ESNT). Federated Pa holds 52,259 shares. Qs Investors Ltd Liability Co holds 200,879 shares or 0.07% of its portfolio. Old Mutual Investors (Uk) Ltd reported 464,294 shares. Int Gru has invested 0.01% of its portfolio in Essent Group Ltd. (NYSE:ESNT). Albion Fincl Group Ut holds 15,829 shares. Connecticut-based Aqr Cap Mgmt Ltd has invested 0.01% in Essent Group Ltd. (NYSE:ESNT). Sei holds 0% in Essent Group Ltd. (NYSE:ESNT) or 8,211 shares. Navellier And Associates reported 12,669 shares or 0.1% of all its holdings. Advisory Ntwk Lc stated it has 0% of its portfolio in Essent Group Ltd. (NYSE:ESNT). Arrowstreet Partnership holds 0.05% or 495,537 shares. Ellington Mngmt Gru Limited Company, a Connecticut-based fund reported 26,500 shares. Zacks Invest Mgmt invested in 0.07% or 71,062 shares.

Among 12 analysts covering Essent Group (NYSE:ESNT), 11 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Essent Group had 44 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was upgraded by Bank of America to “Buy” on Tuesday, May 9. Barclays Capital maintained the stock with “Overweight” rating in Wednesday, September 7 report. As per Tuesday, August 8, the company rating was maintained by Deutsche Bank. On Wednesday, September 28 the stock rating was downgraded by Bank of America to “Neutral”. Keefe Bruyette & Woods maintained the shares of ESNT in report on Monday, May 29 with “Hold” rating. Credit Suisse maintained the stock with “Neutral” rating in Monday, May 2 report. The firm earned “Buy” rating on Monday, February 12 by Compass Point. Deutsche Bank downgraded Essent Group Ltd. (NYSE:ESNT) on Friday, November 3 to “Hold” rating. The firm has “Hold” rating given on Monday, May 1 by Wood. The firm has “Market Perform” rating given on Friday, August 5 by Keefe Bruyette & Woods.

Leave a Reply

Your email address will not be published. Required fields are marked *